Topics
Glioblastoma | Treatment | Targeted therapy | Angiogenes isinhibitors | Failure
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Angiogenes isinhibitors > Failure
*Iwamoto FM, Abrey LE, Beal K, Gutin PH, Rosenblum MK, Reuter VE,
DeAngelis LM, Lassman AB.
Patterns of
relapse and prognosis after bevacizumab failure in recurrent
glioblastoma.
Neurology.
2009 Oct 13;73(15):1200-6. doi:
10.1212/WNL.0b013e3181bc0184. PMID:
19822869. Observational study. ˍ
*Ezaki T, Tanaka T, Tamura R, Ohara K, Yamamoto Y, Takei J,
Morimoto Y, Imai R, Kuranai Y, Akasaki Y, Toda M, Murayama Y,
Miyake K, Sasaki H.
Status of
alternative angiogenic pathways in glioblastoma resected under and
after bevacizumab treatment.
Brain
Tumor Pathol. 2024 Apr 15. doi:
10.1007/s10014-024-00481-0. PMID:
38619734. Observational study; Laboratory investigation. ˍ